Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology: A Systematic Review and Quantitative Analysis.

Overview of attention for article published in JAMA Internal Medicine, December 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 22 news outlets
blogs: 4 blogs
policy: 1 policy source

twitter: 597 X users
facebook: 5 Facebook pages
googleplus: 1 Google+ user

Citations

dimensions_citation: 105 Dimensions

Readers on

mendeley: 134 Mendeley

Summary News Blogs Policy documents X Facebook Google+ Misc. Dimensions citations

So far, Dimensions has found 105 publications that cite this research output.

105

The most recent citing publications are shown below. View all 105 publications that cite this research output on Dimensions.

Association between health-related quality-of-life results, outcomes of efficacy and drug approvals: a meta-research study of randomized phase III trials in oncology

Article in ESMO Open (July 2024)

Health-related quality of life outcomes reporting associated with FDA approvals in haematology and oncology

Article in BMJ Oncology (July 2024)

Research and scholarly methods: Appraising the available literature to inform a research project

Article in JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (June 2024)